113 related articles for article (PubMed ID: 20627566)
21. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
23. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
[TBL] [Abstract][Full Text] [Related]
24. Total synthesis of α-1C-galactosylceramide, an immunostimulatory C-glycosphingolipid, and confirmation of the stereochemistry in the first-generation synthesis.
Liu Z; Byun HS; Bittman R
J Org Chem; 2011 Nov; 76(21):8588-98. PubMed ID: 21958232
[TBL] [Abstract][Full Text] [Related]
25. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.
Taniguchi M; Tashiro T; Dashtsoodol N; Hongo N; Watarai H
Int Immunol; 2010 Jan; 22(1):1-6. PubMed ID: 19858073
[TBL] [Abstract][Full Text] [Related]
26. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of a 2"-deoxy-β-GalCer.
Thakur MS; Khurana A; Kronenberg M; Howell AR
Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535
[TBL] [Abstract][Full Text] [Related]
28. A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids.
Arora P; Venkataswamy MM; Baena A; Bricard G; Li Q; Veerapen N; Ndonye R; Park JJ; Lee JH; Seo KC; Howell AR; Chang YT; Illarionov PA; Besra GS; Chung SK; Porcelli SA
J Am Chem Soc; 2011 Apr; 133(14):5198-201. PubMed ID: 21425779
[TBL] [Abstract][Full Text] [Related]
29. Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY alpha-galactosylceramide.
Vo-Hoang Y; Micouin L; Ronet C; Gachelin G; Bonin M
Chembiochem; 2003 Jan; 4(1):27-33. PubMed ID: 12512073
[TBL] [Abstract][Full Text] [Related]
30. The role of iNKT cells in the immunopathology of systemic lupus erythematosus.
Gabriel L; Morley BJ; Rogers NJ
Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides.
Xing GW; Wu D; Poles MA; Horowitz A; Tsuji M; Ho DD; Wong CH
Bioorg Med Chem; 2005 Apr; 13(8):2907-16. PubMed ID: 15781400
[TBL] [Abstract][Full Text] [Related]
32. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.
Wilson SB; Delovitch TL
Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.
Raju R; Castillo BF; Richardson SK; Thakur M; Severins R; Kronenberg M; Howell AR
Bioorg Med Chem Lett; 2009 Aug; 19(15):4122-5. PubMed ID: 19535248
[TBL] [Abstract][Full Text] [Related]
34. Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation.
Blauvelt ML; Khalili M; Jaung W; Paulsen J; Anderson AC; Brian Wilson S; Howell AR
Bioorg Med Chem Lett; 2008 Dec; 18(24):6374-6. PubMed ID: 18993065
[TBL] [Abstract][Full Text] [Related]
35. The in vivo response of invariant natural killer T cells to glycolipid antigens.
Parekh VV; Lalani S; Van Kaer L
Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells.
Lu X; Song L; Metelitsa LS; Bittman R
Chembiochem; 2006 Nov; 7(11):1750-6. PubMed ID: 17009272
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ
Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567
[TBL] [Abstract][Full Text] [Related]
38. RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines.
Fuhshuku K; Hongo N; Tashiro T; Masuda Y; Nakagawa R; Seino K; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Jan; 16(2):950-64. PubMed ID: 17950609
[TBL] [Abstract][Full Text] [Related]
39. Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
Gately CM; Podbielska M; Counihan T; Hennessy M; Leahy T; Moran AP; Hogan EL; O'Keeffe J
J Neuroimmunol; 2013 Jun; 259(1-2):1-7. PubMed ID: 23537888
[TBL] [Abstract][Full Text] [Related]
40. Alpha-c-galactosylceramides: synthesis and immunology.
Franck RW; Tsuji M
Acc Chem Res; 2006 Oct; 39(10):692-701. PubMed ID: 17042469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
